<DOC>
	<DOCNO>NCT00598780</DOCNO>
	<brief_summary>To evaluate period 6 month safety treatment satisfaction newly prescribe levocetirizine patient age ≥ 2 year persistent allergic rhinitis .</brief_summary>
	<brief_title>Evaluation Safety Levocetirizine Routine Clinical Practice-non- Interventional Study</brief_title>
	<detailed_description>This non-interventional , prospective , post-authorization , multi-centre cohort study patient treat levocetirizine . The baseline data collect visit physician levocetirizine prescribe first time patient Persistent Allergic Rhinitis . The data collect 2 visit occur within first 6 month treatment , usually schedule normal clinical practice Czech Slovak Republics . This approximately 4 week 6 month treatment earlier , treatment stop</detailed_description>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>diagnosis persistent allergic rhinitis first prescription levocetirizine diagnosis patient age ≥ 2 year indication define inclusion criterion history allergic anaphylactic reaction levocetirizine derivative excipients include</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Levocetirizine</keyword>
	<keyword>Xyzal</keyword>
	<keyword>Rhinitis allergic persistent</keyword>
	<keyword>Rhinitis nonseasonal</keyword>
</DOC>